Triglycerides blood test
Triglycerides. Also called: TG, Serum triglycerides, Triacylglycerols
Triglycerides are the main fat in the blood, carried in VLDL and other triglyceride-rich particles. Below 150 mg/dL is normal; 500 or higher is very high. They rise after meals, so a non-fasting result can read higher than a fasting one.
One of the four values on a standard Lipid Panel. The panel page also covers the advanced tests, ApoB and Lp(a).
At a glance
| What it measures | The triglyceride (fat) carried in the blood, mostly in VLDL and other triglyceride-rich particles. |
|---|---|
| Sample | Serum or plasma. Non-fasting is fine in a lipid panel; a standalone triglyceride test asks for an overnight fast. |
| Adult categories | Normal below 150 mg/dL; borderline high 150-199; high 200-499; very high 500 or higher. |
| Peptides that move it | Lowered by Tirzepatide, Semaglutide, Liraglutide and Tesamorelin; raised by GnRH drugs. |
| Lab code | LOINC 2571-8 (Labcorp 001172, Quest 896) |
What are Triglycerides?
Triglycerides are the main form of fat in the blood. They travel in triglyceride-rich lipoproteins such as VLDL. Partly broken-down VLDL particles, called remnant lipoproteins, are treated by ATP III as atherogenic. High triglycerides predict heart disease and, when very high, acute pancreatitis.
How it is made and regulated
Where it is made
ATP III lists the usual drivers of high triglycerides: obesity and overweight, physical inactivity, cigarette smoking, excess alcohol, very high-carbohydrate diets (more than 60% of energy), type 2 diabetes, chronic kidney failure, nephrotic syndrome, some drugs (corticosteroids, estrogens, retinoids, high-dose beta-blockers) and inherited disorders.
What controls it
Triglycerides rise after each meal and then fall as the particles are cleared. Weight loss and physical activity lower them; ATP III notes that regular activity reduces VLDL.
How it travels in the blood
Labs measure triglycerides enzymatically in serum or plasma. The value also feeds the LDL calculation: the Friedewald formula is less accurate at triglycerides of 400 mg/dL or more, which the NIH equation was built to handle.
How long it lasts
Triglycerides are the lipid most affected by eating: the largest average rise 1 to 6 hours after normal meals is about 26 mg/dL (0.3 mmol/L). The European consensus suggests a fasting sample when non-fasting triglycerides are above 440 mg/dL.
Sources: [5]
What it does
In 7,587 women and 6,394 men from Copenhagen followed for a mean of 26 years, higher non-fasting triglycerides predicted heart attacks, ischemic heart disease and death. In 116,550 people, the risk of acute pancreatitis rose with triglycerides, to 8.7 times at 443 mg/dL or higher compared with below 89 mg/dL.
Reference ranges
Triglycerides are read against risk categories. Labcorp prints 0-149 mg/dL; Quest prints below 150 for adults with lower limits for children; ATP III sets normal, borderline high, high and very high.
Labcorp (test 303756)
| Group | Range (mg/dL) |
|---|---|
| Adults (sample reports for women aged 31 and 64) | 0-149 |
Values above 149 are flagged high.
Quest Diagnostics (test 896)
| Group | Range (mg/dL) |
|---|---|
| 20 years and older | <150 |
Children and teens
| Group | Range (mg/dL) |
|---|---|
| 9 years and under | <75 |
| 10-19 years | <90 |
Read from Quest's test directory for the East service area.
NCEP Adult Treatment Panel III (NHLBI)
| Group | Range (mg/dL) |
|---|---|
| Normal | <150 |
| Borderline high | 150-199 |
| High | 200-499 |
| Very high | 500 or higher |
ATP III triglyceride classification. The 2018 AHA/ACC guideline counted persistent triglycerides of 175 mg/dL or higher as a risk-enhancing factor.
Triglycerides vary more than the other lipids and rise after eating, so a single high non-fasting value is worth repeating.
Units: Labs outside the US report triglycerides in mmol/L. Divide mg/dL by 88 to convert, the factor used in the European lipid consensus: 150 mg/dL is about 1.7 mmol/L. [5]
What raises it
| Factor | How | How much |
|---|---|---|
| Recent mealPhysiology | Triglyceride-rich particles from the gut enter the blood after eating. | Largest average rise about 26 mg/dL, 1-6 hours after normal meals [5] |
| Obesity, inactivity, smoking, excess alcohol, high-carbohydrate dietLifestyle | ATP III's list of common causes of high triglycerides. | No published magnitude [1] |
| Type 2 diabetes, chronic kidney failure, nephrotic syndromeCondition | Diseases ATP III lists as raising triglycerides. | No published magnitude [1] |
| Corticosteroids, estrogens, retinoids, high-dose beta-blockersMedication | Drugs ATP III lists as raising triglycerides. | No published magnitude [1] |
| GnRH drugs (Goserelin, Leuprolide)Peptide | Sex-hormone suppression raises triglycerides. | +8.0 mg/dL over 6 months on goserelin in women with endometriosis [13] [14] |
What lowers it
| Factor | How | How much |
|---|---|---|
| GLP-1 and GIP/GLP-1 drugsPeptide | Triglycerides fell more than any other lipid in the obesity trials of Tirzepatide and Semaglutide. | -29.1% vs -5.6% on placebo (tirzepatide 15 mg) [6] [15] |
| TesamorelinPeptide | Triglycerides fell with visceral fat in people with HIV. | -50 mg/dL vs +9 mg/dL on placebo over 26 weeks [16] |
| Physical activityLifestyle | ATP III notes that regular activity lowers VLDL. | No published magnitude [1] |
Peptides that affect Triglycerides
How each peptide in our library changes triglycerides, from FDA label tables and trials. No study has measured triglycerides after dosing CJC-1295, Ipamorelin, HGH Fragment 176-191 or AOD-9604; a PubMed search for each peptide with cholesterol, triglycerides or lipids finds no human data (the only AOD-9604 lipid paper is a mouse study of fat loss, not blood lipids).
| Peptide | Effect on Triglycerides | Size of effect | Evidence |
|---|---|---|---|
| MK-677 (Ibutamoren) | Raises | No figure in the abstract: in obese men, serum triglycerides rose at 2 weeks of MK-677; the authors describe the effect as transientA short-lived rise early in treatment. [17] | Human trials |
| Tesamorelin | Lowers | 26 weeks in people with HIV and abdominal fat: triglycerides -50 mg/dL vs +9 mg/dL on placebo (P < 0.001). A second trial: -37 mg/dL vs +6 mg/dLTriglycerides fell together with visceral fat in two randomized trials. [16] [18] | Human trials |
| Goserelin | Raises | Women treated for endometriosis, 6 months: triglycerides +8.0 mg/dL on goserelin (danazol: a decrease)A small rise during estrogen suppression. [13] | FDA label |
| Leuprolide | Raises | No size given: hyperlipidemia including triglycerides was recorded in 5% or more of men with prostate cancerThe label asks for lipid monitoring on GnRH agonists. [14] | FDA label |
| Liraglutide | Lowers | Saxenda 3 mg (Study 1, adults without diabetes): triglycerides -13% vs -4.1% on placebo; relative difference -7.1%A moderate fall in the weight-management trial. [19] | FDA label |
| Semaglutide | Lowers | Wegovy 2.4 mg, 68 weeks (adults with obesity or overweight): triglycerides -21.9% vs -7.3% on placebo; relative difference -15.8%The largest lipid change semaglutide produces. [15] | FDA label |
| Tirzepatide | Lowers | Zepbound 15 mg, 72 weeks (Study 1): triglycerides -29.1% vs -5.6% on placebo; relative difference -24.9%A large, dose-related fall. [6] | FDA label |
What high or low results can mean
A high result
150-199 mg/dL is borderline high, 200-499 high and 500 or higher very high. High triglycerides track with heart attacks; very high levels also raise the risk of acute pancreatitis.
- A recent meal (non-fasting sample)
- Obesity, inactivity or excess alcohol
- Type 2 diabetes or kidney disease
- Drugs such as corticosteroids or estrogens
A low result
Below 150 mg/dL is normal. Low triglycerides are not usually a concern.
- Fasting sample
- Lean, active lifestyle
How the test works
| Sample | Serum (preferred) or plasma, 1 mL at Labcorp. Labcorp rejects samples in glycerinated tubes. |
|---|---|
| Fasting | In a lipid panel fasting is not required. For a standalone triglyceride test, Labcorp asks for an overnight fast (12 hours preferred, 8 acceptable) and Quest for 9-12 hours. The European Atherosclerosis Society and EFLM recommend routine non-fasting lipid profiles: after normal meals, the largest average changes are +26 mg/dL for triglycerides and -8 mg/dL for total and LDL cholesterol, while HDL does not change. They suggest a fasting sample when non-fasting triglycerides are above 440 mg/dL. |
| Timing | Triglycerides peak 1 to 6 hours after a meal, so the time since your last meal affects the result. |
| Lab differences | Enzymatic assay at Labcorp; spectrophotometry at Quest. Very high triglycerides make a calculated LDL less accurate. |
| Retesting | A single high non-fasting value is worth repeating, ideally fasting, before drawing conclusions. |
| Labcorp order code | 001172: Triglycerides |
| Labcorp order code | 303756: Lipid Panel |
| Quest Diagnostics order code | 896: Triglycerides |
| Quest Diagnostics order code | 7600: Lipid Panel, Standard |
| LOINC codes |
|
History
Triglycerides moved from a fasting-only measurement to an accepted non-fasting marker of heart risk.
- 1977In older Framingham adults, triglycerides predict heart disease only in women, and only when other lipids are not taken into account. [21]
- 2001NCEP ATP III lowers the triglyceride cut-points and sets the normal, borderline, high and very high categories. [1] [2]
- 2007Copenhagen data show elevated non-fasting triglycerides predict heart attacks and death. [3]
- 2016European societies recommend routine non-fasting lipid profiles; mild-to-moderate high triglycerides are linked to acute pancreatitis. [5] [4]
FAQ
What is a normal triglyceride level?
Below 150 mg/dL for adults (ATP III, Labcorp 0-149, Quest below 150). Quest uses below 75 for children 9 and under and below 90 for ages 10-19.
Do I need to fast?
Not for a lipid panel. For a standalone triglyceride test Labcorp asks for an overnight fast and Quest 9-12 hours. A meal raises triglycerides by about 26 mg/dL at most.
When should I repeat a test fasting?
The European consensus suggests a fasting sample when non-fasting triglycerides are above 440 mg/dL.
Sources: [5]
What does 500 mg/dL or higher mean?
Very high in ATP III. Very high triglycerides raise the risk of acute pancreatitis: risk was 8.7 times higher at 443 mg/dL or more than below 89 mg/dL in a large Danish study.
Are triglycerides linked to heart disease?
Yes. In Copenhagen adults followed for 26 years, higher non-fasting triglycerides predicted heart attacks, ischemic heart disease and death. The 2018 AHA/ACC guideline counted persistent triglycerides of 175 mg/dL or higher as a risk-enhancing factor.
What raises triglycerides?
ATP III lists obesity, inactivity, smoking, excess alcohol, high-carbohydrate diets, type 2 diabetes, kidney disease and drugs such as corticosteroids, estrogens and retinoids.
Sources: [1]
Do GLP-1 drugs lower triglycerides?
Yes, more than any other lipid. In obesity trials triglycerides fell 29.1% on Tirzepatide 15 mg (vs 5.6% on placebo), 21.9% on Semaglutide 2.4 mg and 13% on Liraglutide 3 mg.
How does tesamorelin affect triglycerides?
In a 26-week trial in people with HIV and abdominal fat, triglycerides fell 50 mg/dL on Tesamorelin vs a 9 mg/dL rise on placebo; a second trial found -37 vs +6 mg/dL.
Does MK-677 affect triglycerides?
In obese men, triglycerides rose in the first 2 weeks of MK-677 (Ibutamoren); the authors describe the effect as transient.
Sources: [17]
References
- National Cholesterol Education Program. Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Executive Summary. NIH Publication No. 01-3670. National Heart, Lung, and Blood Institute; 2001. Table 2 (LDL, total and HDL cholesterol classification), triglyceride classification and Table 8 (metabolic syndrome). nhlbi.nih.gov/files/docs/guidelines/atp3xsum.pdf
- Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-97. PMID 11368702
- Nordestgaard BG, Benn M, Schnohr P, et al. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 2007;298(3):299-308. PMID 17635890
- Pedersen SB, Langsted A, Nordestgaard BG. Nonfasting Mild-to-Moderate Hypertriglyceridemia and Risk of Acute Pancreatitis. JAMA Intern Med. 2016;176(12):1834-1842. PMID 27820614
- Nordestgaard BG, Langsted A, Mora S, et al. Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. Eur Heart J. 2016;37(25):1944-58. PMID 27122601
- Zepbound (tirzepatide) injection. FDA prescribing information, Table 3 (cardiometabolic parameters, Studies 1 and 2). dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
- Labcorp. Test 001172: Triglycerides. Methodology, specimen, patient preparation and LOINC map. labcorp.com/tests/001172/triglycerides
- Quest Diagnostics. Test 896: Triglycerides. Test directory: methodology, patient preparation, age-banded reference range and clinical significance. testdirectory.questdiagnostics.com/test/test-detail/896/triglycerides?cc=PHP
- Sampson M, Ling C, Sun Q, et al. A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia. JAMA Cardiol. 2020;5(5):540-548. PMID 32101259
- Labcorp. Sample report, test 303756 (Lipid Panel): reference intervals as printed for a 31-year-old woman (reported 06/10/2024). files.labcorp.com/testmenu-d8/sample_reports/303756.pdf
- Labcorp. Sample report, test 235010 (Lipid Panel With LDL/HDL Ratio): reference intervals as printed for a 64-year-old woman (reported 06/10/2024). files.labcorp.com/testmenu-d8/sample_reports/235010.pdf
- Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139(25):e1082-e1143. PMID 30586774
- Zoladex (goserelin implant) 3.6 mg. FDA prescribing information: lipid changes in women treated for endometriosis. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=294b168b-6e5f-4db9-bf70-d599271458b3
- Lupron Depot (leuprolide acetate) 7.5 mg, 22.5 mg, 30 mg, 45 mg. FDA prescribing information: Warnings (metabolic syndrome) and laboratory abnormalities. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cbc8f94e-7330-4465-05ad-16d64493a5dd
- Wegovy (semaglutide) injection 2.4 mg. FDA prescribing information, Table 10 (cardiometabolic parameters, Study 2). dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
- Falutz J, Allas S, Blot K, et al. Metabolic effects of a growth hormone-releasing factor in patients with HIV. N Engl J Med. 2007;357(23):2359-70. PMID 18057338
- Svensson J, Jansson JO, Ottosson M, et al. Treatment of obese subjects with the oral growth hormone secretagogue MK-677 affects serum concentrations of several lipoproteins, but not lipoprotein(a). J Clin Endocrinol Metab. 1999;84(6):2028-33. PMID 10372705
- Falutz J, Mamputu JC, Potvin D, et al. Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data. J Clin Endocrinol Metab. 2010;95(9):4291-304. PMID 20554713
- Saxenda (liraglutide) injection 3 mg. FDA prescribing information, Table 6 (cardiometabolic parameters, Study 1). dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143
- Labcorp. Test 303756: Lipid Panel. Components, specimen, patient preparation and LOINC map. labcorp.com/tests/303756/lipid-panel
- Gordon T, Castelli WP, Hjortland MC, et al. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med. 1977;62(5):707-14. PMID 193398
- Labcorp. Test 120295: Low-density Lipoprotein Cholesterol (Direct). Methodology, patient preparation and LOINC map. labcorp.com/tests/120295/low-density-lipoprotein-cholesterol-direct
Educational information, not medical advice. Lab ranges and test codes were checked on October 31, 2026. Always use the range printed on your own report, and talk to a clinician about your results.